Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma

Mark A. Henderson, Haider Shirazi, Simon S. Lo, Marc S. Mendonca, Achilles J. Fakiris, Thomas C. Witt, Robert M. Worth, Robert D. Timmerman

Research output: Contribution to journalArticle

15 Scopus citations


Uveal melanoma is the most common primary intraocular malignant tumor. Radiation therapy has now replaced enucleation as the treatment of choice, with radioactive eye plaques and proton therapy being the two most studied radiotherapy modalities. More recently, stereotactic radiosurgery and fractionated stereotactic radiotherapy have emerged as promising, non-invasive treatments for uveal melanoma. This review summarizes the available literature on these newer treatment modalities.

Original languageEnglish (US)
Pages (from-to)411-419
Number of pages9
JournalTechnology in Cancer Research and Treatment
Issue number4
StatePublished - Aug 2006



  • Fractionated Stereotactic Radiotherapy
  • Stereotactic Radiosurgery
  • Uveal Melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this